Mural Oncology PLC Logo

Mural Oncology PLC

Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.

MURA | BUD

Overview

Corporate Details

ISIN(s):
IE000LK2BOB4
LEI:
Country:
Ireland
Address:
N/A
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Mural Oncology PLC is a clinical-stage oncology company focused on developing novel immunotherapies to treat cancer. The company leverages its proprietary protein engineering platform and expertise in cytokine biology to design and advance a pipeline of cytokine-based therapies. Its mission is to unlock the value of immunotherapy for a broader range of patients, particularly those with cancers that have not responded to previous treatments. The company's lead candidate, nemvaleukin alfa, is a novel, engineered interleukin-2 (IL-2) variant immunotherapy currently in clinical trials for difficult-to-treat solid tumors, including advanced melanoma and platinum-resistant ovarian cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-24 22:25
Post-Annual General Meeting Information
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisiti…
English 31.3 KB
2025-09-24 01:52
Proxy Solicitation & Information Statement
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement …
English 18.3 KB

Automate Your Workflow. Get a real-time feed of all Mural Oncology PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mural Oncology PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mural Oncology PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

genOway Logo
Develops custom genetically modified preclinical models for biopharma and academic research.
France
ALGEN
Genpact LTD Logo
Drives business transformation for enterprises using AI, data, and technology services.
United States of America
G
GenSight Biologics S.A. Logo
Developing gene therapies for neurodegenerative diseases of the eye and central nervous system.
France
SIGHT
GeoVax Labs, Inc. Logo
Developing vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
United States of America
GOVX
GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş. Logo
A travel agency offering online booking for transport, hotels, cultural tours, and cruises.
Türkiye
GZNMI
GIG Works Inc. Logo
Connects businesses with gig workers, offering staffing, BPO, IT, and coworking services in Japan.
Japan
2375
An investment company providing global marketing and promotion services, focusing on UK businesses.
Cayman Islands
GCAP
GMO Research & AI, Inc. Logo
Market research tech providing access to 65M+ APAC consumer panelists for data-driven insights.
Japan
3695
GRAIL, Inc. Logo
A biotech company that detects multiple cancers early with a single blood test.
United States of America
GRAL
A gold and copper producer operating and developing mines in Western Australia's Paterson region.
Australia
GGP

Talk to a Data Expert

Have a question? We'll get back to you promptly.